28194562|t|The Iboga Alkaloids
28194562|a|Iboga alkaloids are a particular class of indolomonoterpenes most often characterized by an isoquinuclidine nucleus. Their first occurrence was detected in the roots of Tabernanthe iboga, a sacred plant to the people of Gabon, which made it cult object. Ibogaine is the main representative of this class of alkaloids and its psychoactive properties are well documented. It has been proposed as a drug cessation treatment and has a wide range of activities in targeting opioids, cocaine, and alcohol. The purpose of this chapter is to provide a background on this molecule and related compounds and to update knowledge on the most recent advances made. Difficulties linked to the status of ibogaine as a drug in several countries have hampered its development, but 18-methoxycoronaridine is currently under evaluation for the same purposes and for the treatment of leishmaniasis. The chapter is divided into six parts: an introduction aiming at defining what is called an iboga alkaloid, and this is followed by current knowledge on their biosynthesis, which unfortunately remains a " black box " as far as the key construction step is concerned. Many of these alkaloids are still being discovered and the third and fourth parts of the chapter discuss the analytical tools in use for this purpose and give lists of new monomeric and dimeric alkaloids belonging to this class. When necessary, the structures are discussed especially with regard to absolute configuration determinations, which remain a point of weakness in their assignments. Part V gives an account of progress made in the synthesis, partial and total, which the authors believe is key to providing solid solutions to the industrial development of the most promising molecules. The last part of the chapter is devoted to the biological properties of iboga alkaloids, with particular emphasis on ibogaine and 18-methoxycoronaridine.
28194562	4	19	Iboga Alkaloids	T109,T121	C0598647
28194562	20	35	Iboga alkaloids	T109,T121	C0598647
28194562	53	58	class	T170	C0456387
28194562	62	80	indolomonoterpenes	T109	C0682997
28194562	92	105	characterized	T052	C1880022
28194562	112	135	isoquinuclidine nucleus	T109	C0034439
28194562	149	159	occurrence	T079	C2745955
28194562	164	172	detected	T033	C0442726
28194562	180	185	roots	T002	C0242726
28194562	189	206	Tabernanthe iboga	T002	C0950092
28194562	210	216	sacred	T033	C0557075
28194562	217	222	plant	T002	C0032098
28194562	230	236	people	T098	C0027361
28194562	240	245	Gabon	T083	C0016910
28194562	261	265	cult	T098	C0337775
28194562	266	272	object	T072	C0347997
28194562	274	282	Ibogaine	T109,T121,T123	C0020737
28194562	295	309	representative	T052	C1882932
28194562	318	323	class	T170	C0456387
28194562	327	336	alkaloids	T109,T121	C0002062
28194562	345	357	psychoactive	T121,T131	C0682880
28194562	358	368	properties	T080	C0871161
28194562	378	388	documented	T058	C1301725
28194562	402	410	proposed	T080	C1553874
28194562	416	440	drug cessation treatment	T061	C3161924
28194562	451	455	wide	T082	C0332464
28194562	456	461	range	T081	C1514721
28194562	465	475	activities	T052	C0441655
28194562	479	488	targeting	T169	C1521840
28194562	489	496	opioids	T109,T121	C0029112
28194562	498	505	cocaine	T109,T131	C0009170
28194562	511	518	alcohol	T109,T121	C0001975
28194562	524	531	purpose	T169	C1285529
28194562	540	547	chapter	T078	C1552857
28194562	554	561	provide	T052	C1999230
28194562	564	574	background	T077	C1706907
28194562	583	591	molecule	T167	C0567416
28194562	596	603	related	T080	C0439849
28194562	604	613	compounds	T103	C1706082
28194562	621	627	update	T079	C1519814
28194562	628	637	knowledge	T170	C0376554
28194562	650	656	recent	T079	C0332185
28194562	657	665	advances	T078	C1519201
28194562	672	684	Difficulties	T033	C1299586
28194562	699	705	status	T080	C0332306
28194562	709	717	ibogaine	T109,T121,T123	C0020737
28194562	723	727	drug	T121	C1254351
28194562	739	748	countries	T083	C0454664
28194562	754	762	hampered	T052	C3463820
28194562	767	778	development	T169	C1527148
28194562	784	806	18-methoxycoronaridine	T109	C0533693
28194562	810	819	currently	T079	C0521116
28194562	826	836	evaluation	T058	C0220825
28194562	845	849	same	T080	C0445247
28194562	850	858	purposes	T169	C1285529
28194562	871	880	treatment	T061	C0087111
28194562	884	897	leishmaniasis	T047	C0023281
28194562	903	910	chapter	T078	C1552857
28194562	931	936	parts	T082	C0449719
28194562	941	953	introduction	T170	C4282183
28194562	954	960	aiming	T078	C1947946
28194562	991	1005	iboga alkaloid	T109,T121	C0598647
28194562	1031	1038	current	T079	C0521116
28194562	1039	1048	knowledge	T170	C0376554
28194562	1058	1070	biosynthesis	T169	C0005572
28194562	1104	1113	black box	T077	C1254372
28194562	1130	1133	key	T077	C1706198
28194562	1134	1146	construction	T052	C1883254
28194562	1147	1151	step	T077	C1261552
28194562	1155	1164	concerned	T078	C2699424
28194562	1180	1189	alkaloids	T109,T121	C0002062
28194562	1206	1216	discovered	T052	C1880355
28194562	1242	1247	parts	T082	C0449719
28194562	1255	1262	chapter	T078	C1552857
28194562	1275	1291	analytical tools	T170	C0178476
28194562	1308	1315	purpose	T169	C1285529
28194562	1338	1347	monomeric	T104	C0596973
28194562	1352	1359	dimeric	T104	C0596448
28194562	1360	1369	alkaloids	T109,T121	C0002062
28194562	1388	1393	class	T170	C0456387
28194562	1400	1409	necessary	T080	C3898777
28194562	1415	1425	structures	T170	C0220807
28194562	1440	1450	especially	T080	C0205555
28194562	1466	1474	absolute	T080	C0205344
28194562	1475	1488	configuration	T082	C0026377
28194562	1489	1503	determinations	T059	C1148554
28194562	1520	1525	point	T082	C3714763
28194562	1529	1537	weakness	T080	C1762617
28194562	1547	1558	assignments	T169	C1516050
28194562	1560	1564	Part	T082	C0449719
28194562	1576	1583	account	T170	C0684224
28194562	1587	1595	progress	T169	C1280477
28194562	1608	1617	synthesis	T052	C1883254
28194562	1619	1626	partial	T081	C0728938
28194562	1631	1636	total	T080	C0439810
28194562	1648	1655	authors	T097	C3812881
28194562	1667	1670	key	T077	C1706198
28194562	1674	1683	providing	T052	C1999230
28194562	1684	1689	solid	T080	C0442821
28194562	1690	1699	solutions	T077	C2699488
28194562	1707	1717	industrial	T092	C0007983
28194562	1718	1729	development	T169	C1527148
28194562	1742	1751	promising	T033	C3843166
28194562	1752	1761	molecules	T167	C0567416
28194562	1772	1776	part	T082	C0449719
28194562	1784	1791	chapter	T078	C1552857
28194562	1810	1820	biological	T080	C0205460
28194562	1821	1831	properties	T080	C0871161
28194562	1835	1850	iboga alkaloids	T109,T121	C0598647
28194562	1868	1876	emphasis	T079	C0549179
28194562	1880	1888	ibogaine	T109,T121,T123	C0020737
28194562	1893	1915	18-methoxycoronaridine	T109	C0533693